amitriptyline + desipramine

Amitriptyline + desipramine is a combination of two tricyclic antidepressants (TCAs): amitriptyline and desipramine. Both drugs act primarily by inhibiting the reuptake of monoamine neurotransmitters in the central nervous system, but with different selectivity profiles. Amitriptyline is a relatively selective serotonin reuptake inhibitor with strong anticholinergic and sedative properties, while desipramine is more selective for noradrenaline (norepinephrine) reuptake inhibition and has weaker anticholinergic effects[1][2][3][4][5]. The combination would theoretically provide both serotonergic and noradrenergic enhancement, potentially broadening antidepressant efficacy or altering side effect profiles. Both agents are approved individually for depression; amitriptyline is also used off-label for neuropathic pain syndromes, while desipramine may be used off-label for conditions such as ADHD or irritable bowel syndrome[4][5]. There are no widely recognized fixed-dose combination products of these two drugs on the market.